A different first-choice drug in the medical management of patent ductus arteriosus: Oral paracetamol

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 8, 2013, Pages 825-827

  Yurttutan, Sadik ^a   Oncel, Mehmet Yekta ^a   Arayici, Sema ^a   Uras, Nurdan ^a   Altug, Nahide ^a   Erdeve, Omer ^b   Dilmen, Ugur ^a,c  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Paracetamol; Patent ductus arteriosus; Preterm infant

Indexed keywords

PARACETAMOL;

ARTICLE; CASE STUDY; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; INFANT; MALE; OBSERVATIONAL STUDY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SIDE EFFECT;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; DUCTUS ARTERIOSUS, PATENT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PROSPECTIVE STUDIES;

EID: 84876559568     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.755162     Document Type: Article

References (13)

1. Demirel G, Erdeve O, Dilmen U. Pharmacological Management of PDA: oral versus intravenous medications. Curr Clin Pharmacol. 2012;7: 263-70.
2. Hammerman C, Bin-Nun A, Markovitch E, et al. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011;128:1618-21.
3. Erdeve O, Yurttutan S, Altug N, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2012;97:279-83.
4. Gokmen T, Erdeve O, Altug N, et al. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 2011;158:549-54.
5. Zecca E, Romagnoli C, De Carolis M, et al. Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics 2009;124:480-4
6. Erdeve O, Sarici SU, Sari E, Gok F. Oral-ibuprofen-induced acute renal failure in a preterm infant. Pediatr Nephrol 2008;23:1565-67.
7. Green K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by paracetamol. Prostaglandins 1989;37:311-15. (Pubitemid 19117858)
8. Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J 2005;19: 635-7. (Pubitemid 40471269)
9. Momma K, Takao A. Transplacental cardiovascular effects of four popular analgesics in rats. Am J Obstet Gynecol 1990;62: 1304-10. (Pubitemid 20174063)
10. Peterson RG. Consequences associated with nonnarcotic analgesics in the fetus and newborn. Fed Proc 1985;44:2309-13. (Pubitemid 15066754)
11. Simbi KA, Secchieri S, Rinaldo M, et al. In utero ductal closure following near-term maternal self-medication with nimesulide and acetaminophen. J Obstet Gynaecol 2002;22:440-5.
12. Oncel MY, Yurttutan S, Uras N, et al. An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed. 2013; 98 :F94.
13. Jacqz-Aigrain E, Anderson BJ. Pain control: non-steroidal anti-inflammatory agents. Semin Fetal Neonatal Med 2006;11: 251-9. (Pubitemid 43794851)